Cargando…

Assessing Current Therapeutic Approaches to Decode Potential Resistance Mechanisms in Glioblastomas

Unique astrocytic cell infiltrating growth and glial tumor growth in the confined skull make human glioblastoma (GBM) one of the most difficult cancers to treat in modern medicine. Prognosis for patients is very poor, as they die more or less within 12 months. Patients either die of the cancer itsel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sze, Chun-I, Su, Wan-Pei, Chiang, Ming-Fu, Lu, Chen-Yu, Chen, Yu-An, Chang, Nan-Shan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2013
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601334/ https://www.ncbi.nlm.nih.gov/pubmed/23516171 http://dx.doi.org/10.3389/fonc.2013.00059

Ejemplares similares

Tumor Suppressor WWOX and p53 Alterations and Drug Resistance in Glioblastomas
por: Chiang, Ming-Fu, et al.
Publicado: (2013)

Immunosuppression in Glioblastoma: Current Understanding and Therapeutic Implications
por: Himes, Benjamin T., et al.
Publicado: (2021)

Decoding Melanoma Development and Progression: Identification of Therapeutic Vulnerabilities
por: Eddy, Kevinn, et al.
Publicado: (2021)

Current Therapeutic Advances Targeting EGFR and EGFRvIII in Glioblastoma
por: Padfield, Emily, et al.
Publicado: (2015)

Decoding TROP2 in breast cancer: significance, clinical implications, and therapeutic advancements
por: Yao, Liqin, et al.
Publicado: (2023)

Editorial: Metabolic reprogramming for acquiring therapeutic resistance in glioblastoma
por: Hsu, Tsung-I
Publicado: (2023)

Regulation of Cell Proliferation and Migration in Glioblastoma: New Therapeutic Approach
por: Kim, Yangjin
Publicado: (2013)

Therapeutic Prospects of mRNA-Based Gene Therapy for Glioblastoma
por: Tang, Xiangjun, et al.
Publicado: (2019)

Investigation of the Therapeutic Effect of Doxorubicin Combined With Focused Shockwave on Glioblastoma
por: Liao, Wei-Hao, et al.
Publicado: (2021)

Glioblastoma-on-a-chip construction and therapeutic applications
por: Xie, Zuorun, et al.
Publicado: (2023)

Radiation-Induced Changes in Tumor Vessels and Microenvironment Contribute to Therapeutic Resistance in Glioblastoma
por: Seo, Yun-Soo, et al.
Publicado: (2019)

Complex DNA repair pathways as possible therapeutic targets to overcome temozolomide resistance in glioblastoma
por: Yoshimoto, Koji, et al.
Publicado: (2012)

Lipid droplets and ferroptosis as new players in brain cancer glioblastoma progression and therapeutic resistance
por: Bezawork-Geleta, Ayenachew, et al.
Publicado: (2022)

Resistance mechanisms in BRAF(V600E) paediatric high-grade glioma and current therapeutic approaches
por: Lehmann, R., et al.
Publicado: (2022)

Imposing Phase II and Phase III Clinical Trials of Targeted Drugs for Glioblastoma: Current Status and Progress
por: Wang, Yaning, et al.
Publicado: (2021)

Glioblastoma Multiforme: An Overview of Emerging Therapeutic Targets
por: Taylor, Olivia G., et al.
Publicado: (2019)

Current Options and Future Directions in Immune Therapy for Glioblastoma
por: Lynes, John, et al.
Publicado: (2018)

Targeting SOX2 as a Therapeutic Strategy in Glioblastoma
por: Garros-Regulez, Laura, et al.
Publicado: (2016)

MLK3 Is Associated With Poor Prognosis in Patients With Glioblastomas and Actin Cytoskeleton Remodeling in Glioblastoma Cells
por: Zhu, Yan, et al.
Publicado: (2021)

Tumour microenvironment landscape and immunotherapy response in bladder cancer decoded by stromal MOXD1 based on copper-related genes signature
por: Wang, Wenhao, et al.
Publicado: (2022)

Distinct Tumor Microenvironment at Tumor Edge as a Result of Astrocyte Activation Is Associated With Therapeutic Resistance for Brain Tumor
por: Lin, Chiu-Min, et al.
Publicado: (2019)

Radiomics in Glioblastoma: Current Status and Challenges Facing Clinical Implementation
por: Chaddad, Ahmad, et al.
Publicado: (2019)

Construction of an immune-related gene signature for the prognosis and diagnosis of glioblastoma multiforme
por: Yu, Ziye, et al.
Publicado: (2022)

Targeting M-MDSCs enhances the therapeutic effect of BNCT in the 4-NQO-induced murine head and neck squamous cell carcinoma model
por: Chang, Chun-Hsiang, et al.
Publicado: (2023)

Combined Modality Approaches in the Management of Adult Glioblastoma
por: Shirazi, Haider A., et al.
Publicado: (2011)

Radiation-Induced Alterations in the Recurrent Glioblastoma Microenvironment: Therapeutic Implications
por: Gupta, Kshama, et al.
Publicado: (2018)

Prognostic and Therapeutic Roles of the Insulin Growth Factor System in Glioblastoma
por: Tirrò, Elena, et al.
Publicado: (2021)

Glioblastoma Microenvironment: From an Inviolable Defense to a Therapeutic Chance
por: Di Nunno, Vincenzo, et al.
Publicado: (2022)

GFAPδ: A Promising Biomarker and Therapeutic Target in Glioblastoma
por: Radu, Roxana, et al.
Publicado: (2022)

Glioblastoma and the search for non-hypothesis driven combination therapeutics in academia
por: Johanssen, Timothy, et al.
Publicado: (2023)

Editorial: Endocrine malignancies: from pathophysiology to current clinical and surgical therapeutic approaches
por: Tarallo, M., et al.
Publicado: (2023)

Decoding the Roles of Long Noncoding RNAs in Hepatocellular Carcinoma
por: Wong, Lok-Sze, et al.
Publicado: (2021)

Targeting Glioblastoma: The Current State of Different Therapeutic Approaches
por: Khan, Imran, et al.
Publicado: (2021)

Editorial: WW Domain Proteins in Signaling, Cancer Growth, Neural Diseases, and Metabolic Disorders
por: Chang, Nan-Shan, et al.
Publicado: (2019)

ALK receptor activation, ligands and therapeutic targeting in glioblastoma and in other cancers
por: Wellstein, Anton
Publicado: (2012)

The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma
por: Cheng, Fangling, et al.
Publicado: (2019)

The AlkB Family: Potential Prognostic Biomarkers and Therapeutic Targets in Glioblastoma
por: Feng, Songshan, et al.
Publicado: (2022)

A Pyroptosis-Related Gene Signature for Predicting Survival in Glioblastoma
por: Li, Xin-Yu, et al.
Publicado: (2021)

Integrins and p53 pathways in glioblastoma resistance to temozolomide
por: Martin, Sophie, et al.
Publicado: (2012)

An overview of glioblastoma multiforme and temozolomide resistance: can LC-MS-based proteomics reveal the fundamental mechanism of temozolomide resistance?
por: Teraiya, Milan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ndshku08bajr99vhuaiiud27gi